Target Identification | Prioritization

Target Discovery is pivotal in formulating a successful drug campaign. Increasing amounts of scientific literature available in the public domain is an excellent resource to help identify possible drug targets. However, a surge in published literature poses a challenge for researchers to extract relevant information and remain updated with the latest developments.

 Molecular Connections’ Target Identification Service helps pharmaceutical and biotech companies identify novel drug targets along with helping them mine safety data. Our highly skilled domain experts provide our clients with especially curated data in the desired format.

Select Case Studies

  • Molecular Connections’ custom-curation services team assisted a top pharmaceutical company to step up the target discovery/ prioritization process by mining information on various biomedical entities of the specific targets and integrating the information onto the customers internal database. 
  • Target safety data was manually curated from scientific literature for a list of molecular targets and drugs provided by the pharmaceutical company in order to prioritize targets for further research.
case studies
Follow Us on

Dive Deeper

Request additional information on Target Identification | Prioritization

Got questions? Need more info? Fill out the form and our team will get back to you soon.

We use cookies to improve your browsing experience and ensure the proper functioning of our website. By continuing to use our site, you consent to the use of cookies. You can learn more about how we use cookies in our Cookie Policy.